204 related articles for article (PubMed ID: 918794)
1. The binding of antituberculous drugs to normal and kwashiorkor serum.
Buchanan N; van der Walt LA
S Afr Med J; 1977 Sep; 52(13):522-5. PubMed ID: 918794
[TBL] [Abstract][Full Text] [Related]
2. [Determinations of concentration of tuberculostatics].
Boman G
Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2394-5. PubMed ID: 4446014
[No Abstract] [Full Text] [Related]
3. Clinical pharmacokinetics of the antituberculosis drugs.
Holdiness MR
Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
[TBL] [Abstract][Full Text] [Related]
4. [Binding of serum proteins to tuberculostatics].
HARTWIG H; SEITZ U
Z Tuberk; 1956; 109(3):142-50. PubMed ID: 13402061
[No Abstract] [Full Text] [Related]
5. The binding of phenobarbitone and phenytoin to kwashiorkor serum.
Buchanan N; van der Walt LA
S Afr Med J; 1977 Sep; 52(13):518-21. PubMed ID: 72418
[TBL] [Abstract][Full Text] [Related]
6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
7. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
Reutgen H
Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
[No Abstract] [Full Text] [Related]
8. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Mkrtchian SV; Ushkin VV
Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
[No Abstract] [Full Text] [Related]
9. [Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid].
Zeliger LR; Kivman GIa; Makarova RA; Chaĭkovskaia SM
Antibiotiki; 1982 Mar; 27(3):173-6. PubMed ID: 6807194
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
11. Drug-protein binding and protein energy malnutrition.
Buchanan N
S Afr Med J; 1977 Oct; 52(18):733-7. PubMed ID: 601647
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
Acocella G; Conti R; Luisetti M; Pozzi E; Grassi C
Am Rev Respir Dis; 1985 Sep; 132(3):510-5. PubMed ID: 4037525
[TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
[TBL] [Abstract][Full Text] [Related]
14. [Clinical problems on the binding of protein to antituberculous drugs (author's transl)].
Aoyagi T
Kekkaku; 1977 Sep; 52(9):459-68. PubMed ID: 916498
[No Abstract] [Full Text] [Related]
15. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
16. [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors].
Sifuentes-Osornio J; Ponce-de-León LA; Camacho-Mezquita FE; Bobadilla-del-Valle JM; Infante-Suárez ML; Ramírez-Fernández N; Hernández-Gómez L; Nelson AM
Rev Invest Clin; 1995; 47(4):273-81. PubMed ID: 8525129
[TBL] [Abstract][Full Text] [Related]
17. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Pilipchuk NS
Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
[No Abstract] [Full Text] [Related]
18. Binding of rifampicin by human plasma proteins.
Boman G; Ringberger VA
Eur J Clin Pharmacol; 1974 Aug; 7(5):369-73. PubMed ID: 4138537
[No Abstract] [Full Text] [Related]
19. INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status.
Eriksson M; Bolme P; Habte D; Paalzow L
Acta Paediatr Scand; 1988 Nov; 77(6):890-4. PubMed ID: 3144828
[TBL] [Abstract][Full Text] [Related]
20. Contact dermatitis to antituberculosis drugs.
Holdiness MR
Contact Dermatitis; 1986 Nov; 15(5):282-8. PubMed ID: 3545669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
